CreatorsPublishersAdvertisers
View more in
Stocks

Acceleron's stock gains 3.9% on acquisition report

MarketWatch
MarketWatch
 22 days ago
Cover picture for the article

Shares of Acceleron Pharma Inc. gained 3.9% in premarket trading on Monday after Bloomberg reported Friday that an unnamed buyer is considering spending $11 billion to buy the company. Acceleron markets one approved therapy, Reblozy, which is used to treat anemia in some people with the blood disorder beta thalassemia. The company's stock has gained 31.0% so far this year, while the broader S&P 500 is up 18.6%.

www.marketwatch.com

Comments / 0

Comments / 0